Connor, Clark & Lunn Investment Management (CC&L)
ARQT icon

Connor, Clark & Lunn Investment Management (CC&L)’s Arcutis Biotherapeutics ARQT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-119,029
Closed -$1.31M – 1303
2023
Q1 		$1.31M Buy
119,029
+8,303
+7% +$91.3K 0.01% 650
2022
Q4 		$1.64M Buy
+110,726
New +$1.64M 0.01% 596